Zapping the brain to fight Alzheimer's: a new hope?
NCT ID NCT03880240
First seen Mar 22, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This early-phase study tested a non-invasive brain stimulation method called tACS in 17 people with mild to moderate Alzheimer's. The goal was to see if daily sessions over 2-4 weeks could safely reduce harmful amyloid and tau proteins in the brain and possibly improve thinking and memory. While the approach is promising, the study was small and focused on safety and brain changes, not on proving a cure or long-term benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.